Ian Wilson1, G. S. Almeida1, Huw
D. Thomas2, David R. Newell2, Ross J. Maxwell1
1Newcastle MR Centre,
Newcastle University, Newcastle Upopn Tyne, Tyne and Wear, United Kingdom; 2Northern
Institute of cancer Research, Newcastle
University, Newcastle Upon Tyne, Tyne and wear, United Kingdom
Our focus is on the development of MR and PET imaging agents for the evaluation of novel cancer treatments.